Literature DB >> 16217065

Three-dimensional preoperative maps of hippocampal atrophy predict surgical outcomes in temporal lobe epilepsy.

J J Lin1, N Salamon, R A Dutton, A D Lee, J A Geaga, K M Hayashi, A W Toga, J Engel, P M Thompson.   

Abstract

The authors used surface-based anatomic mapping to detect features of hippocampal anatomy that correlated with surgical outcomes in patients undergoing surgery for mesial temporal lobe epilepsy with hippocampal sclerosis. Compared with a seizure-free group, hippocampal profiles for the non-seizure-free group had greater diffuse ipsilateral atrophy and more region-specific contralateral atrophy in the anterior, lateral hippocampus. These atrophic regions may indicate areas of increased epileptogenicity, contributing to poorer surgical outcomes.

Entities:  

Mesh：

Year:  2005        PMID： 16217065      PMCID： PMC2770433          DOI： 10.1212/01.wnl.0000179003.95838.71

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  8 in total

1.  Factors predicting outcome of surgery for intractable epilepsy with pathologically verified mesial temporal sclerosis.

Authors:  Steven G Hardy; John W Miller; Mark D Holmes; Donald E Born; George A Ojemann; Carl B Dodrill; Danial K Hallam
Journal:  Epilepsia       Date:  2003-04       Impact factor: 5.864

2.  Kainic acid-induced dorsal and ventral hippocampal seizures in rats.

Authors:  K Akaike; S Tanaka; H Tojo; S Fukumoto; S Imamura; M Takigawa
Journal:  Brain Res       Date:  2001-05-04       Impact factor: 3.252

3.  Volumetric magnetic resonance imaging evidence of bilateral hippocampal atrophy in mesial temporal lobe epilepsy.

Authors:  M Quigg; E H Bertram; T Jackson; E Laws
Journal:  Epilepsia       Date:  1997-05       Impact factor: 5.864

4.  Access to the posterior medial temporal lobe structures in the surgical treatment of temporal lobe epilepsy.

Authors:  D D Spencer; S S Spencer; R H Mattson; P D Williamson; R A Novelly
Journal:  Neurosurgery       Date:  1984-11       Impact factor: 4.654

5.  A randomized, controlled trial of surgery for temporal-lobe epilepsy.

Authors:  S Wiebe; W T Blume; J P Girvin; M Eliasziw
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

6.  Mapping hippocampal and ventricular change in Alzheimer disease.

Authors:  Paul M Thompson; Kiralee M Hayashi; Greig I De Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; Michael S Hong; David H Herman; David Gravano; David M Doddrell; Arthur W Toga
Journal:  Neuroimage       Date:  2004-08       Impact factor: 6.556

7.  Structural abnormalities in the brains of human subjects who use methamphetamine.

Authors:  Paul M Thompson; Kiralee M Hayashi; Sara L Simon; Jennifer A Geaga; Michael S Hong; Yihong Sui; Jessica Y Lee; Arthur W Toga; Walter Ling; Edythe D London
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

8.  Distribution of pyramidal cell density and hyperexcitability in the epileptic human hippocampal formation.

Authors:  T L Babb; J P Lieb; W J Brown; J Pretorius; P H Crandall
Journal:  Epilepsia       Date:  1984-12       Impact factor: 5.864
  8 in total
  28 in total

1.  New approaches to structural and functional imaging in focal epilepsy.

Authors:  Jerome Engel; Massoud Akhtari; Anatol Bragin; Itzhak Fried; Jennifer A Ogren; Richard J Staba; Noriko Salamon; Paul M Thompson
Journal:  Epilepsia       Date:  2010-02       Impact factor: 5.864

Review 2.  Towards multimodal atlases of the human brain.

Authors:  Arthur W Toga; Paul M Thompson; Susumu Mori; Katrin Amunts; Karl Zilles
Journal:  Nat Rev Neurosci       Date:  2006-12       Impact factor: 34.870

Review 3.  Mesial temporal lobe epilepsy: How do we improve surgical outcome?

Authors:  Maria Thom; Gary W Mathern; J Helen Cross; Edward H Bertram
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

Review 4.  Brain mapping as a tool to study neurodegeneration.

Authors:  Liana G Apostolova; Paul M Thompson
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

5.  Three-dimensional hippocampal atrophy maps distinguish two common temporal lobe seizure-onset patterns.

Authors:  Jennifer A Ogren; Anatol Bragin; Charles L Wilson; Gil D Hoftman; Jack J Lin; Rebecca A Dutton; Tony A Fields; Arthur W Toga; Paul M Thompson; Jerome Engel; Richard J Staba
Journal:  Epilepsia       Date:  2008-11-19       Impact factor: 5.864

6.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-11-08       Impact factor: 6.556

7.  Reduced caudate nuclei volumes in patients with congenital central hypoventilation syndrome.

Authors:  R Kumar; R Ahdout; P M Macey; M A Woo; C Avedissian; P M Thompson; R M Harper
Journal:  Neuroscience       Date:  2009-07-24       Impact factor: 3.590

8.  Three-dimensional surface mapping of the caudate nucleus in late-life depression.

Authors:  Meryl A Butters; Howard J Aizenstein; Kiralee M Hayashi; Carolyn C Meltzer; Jamie Seaman; Charles F Reynolds; Arthur W Toga; Paul M Thompson; James T Becker
Journal:  Am J Geriatr Psychiatry       Date:  2009-01       Impact factor: 4.105

9.  Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 10.  Biomarkers for epileptogenesis and its treatment.

Authors:  Jerome Engel; Asla Pitkänen
Journal:  Neuropharmacology       Date:  2019-08-01       Impact factor: 5.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.